Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2001 May;85(5):537-9.
doi: 10.1136/bjo.85.5.537.

A randomised, double masked, clinical trial of high dose vitamin A and vitamin E supplementation after photorefractive keratectomy

Affiliations
Clinical Trial

A randomised, double masked, clinical trial of high dose vitamin A and vitamin E supplementation after photorefractive keratectomy

M Vetrugno et al. Br J Ophthalmol. 2001 May.

Abstract

Aim: To evaluate the effect of a high dose vitamin A and E supplementation on corneal re-epithelialisation time, visual acuity and haze following photorefractive keratectomy (PRK).

Methods: Two groups of 20 patients who underwent myopic PRK were supplemented with either 25 000 IU retinol palmitate and 230 mg alpha tocopheryl nicotinate or a placebo. Clinical outcomes were evaluated up to 360 days.

Results: In the vitamin treated group, re-epithelialisation time was significantly faster (p = 0.029) and haze incidence was reduced (p = 0.035), especially for high myopic corrections (p = 0.043). This group also reported a significantly better uncorrected visual acuity (p = 0.043).

Conclusions: High dose vitamin A and E oral supplementation may accelerate re-epithelialisation time and may reduce corneal haze formation after PRK.

PubMed Disclaimer

References

    1. Eur J Ophthalmol. 2000 Jan-Mar;10(1):32-8 - PubMed
    1. Ophthalmic Surg Lasers. 2000 Sep-Oct;31(5):400-10 - PubMed
    1. Am J Ophthalmol. 1991 Mar 15;111(3):372-4 - PubMed
    1. Invest Ophthalmol Vis Sci. 1994 Apr;35(5):2405-20 - PubMed
    1. Invest Ophthalmol Vis Sci. 1999 May;40(6):1245-9 - PubMed

Publication types